Financial insights of BIAFW

MyFinsight

For the quarter ending 2025-09-30, BIAFW made $1,446,066 in revenue. -$5,051,084 in net income. Net profit margin of -349.30%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30
Net revenue	1,446,066	1,269,483
Direct costs and expenses	942,211	1,016,602
Research and development	330,589	311,372
Clinical development	143,311	129,279
Selling, general and administrative	2,209,441	2,214,561
Depreciation and amortization	113,360	113,229
Total operating expenses	3,738,912	3,785,043
Loss from operations	-2,292,846	-2,515,560
Interest income	1,088	2,025
Interest expense	5,358	10,460
Other income	513	38,053
Other expense	3,839	483,043
Change in fair value of warrants issued	2,747,460	1,062,818
Total other income (expense), net	-2,755,056	-1,516,243
Net loss before provision for income tax expense	-5,047,902	-4,031,803
Provision for income tax expense	3,182	28,984
Net loss	-5,051,084	-4,060,787

Net loss per common share, basic	-4.74	-0.17
Net loss per common share, diluted	-4.74	-0.17
Weighted average common shares outstanding, basic	1,066,350	24,021,546
Weighted average common shares outstanding, diluted	1,066,350	24,021,546